law360.com
The U.S. Department of Justice and state attorneys general have sued generic
drug companies and executives over allegations of price-fixing and
market-sharing, and experts expect the fray to greatly expand in 2017,
encompassing many more individuals and companies and possibly growing beyond
manufact…
over 2 years ago